Judge accepts Paxil deal

Share this article:
An Illinois judge approved a $64-million class-action deal involving anti-depressant Paxil. The agreement, under which plaintiffs can get full refunds for their Paxil purchases, settles claims GlaxoSmithKline misled consumers by promoting the drug to children. Parties in the suit originally made the arrangement last November, contingent on a hearing to determine whether the settlement was fair and whether plaintiff’s attorneys were entitled to the $16 million settlement fee they requested. Last year the FDA issued warnings against use of Paxil in children after studies found the drug increased suicidal tendencies while having questionable effects on depression.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.